APA (7th ed.) Citation

Papatsirou, M., Kontos, C. K., Ntanasis‐Stathopoulos, I., Malandrakis, P., Sideris, D. C., Fotiou, D., . . . Terpos, E. (2024). Exploring the molecular biomarker utility of circCCT3 in multiple myeloma: A favorable prognostic indicator, particularly for R‐ISS II patients. Wiley. https://doi.org/10.1002/hem3.34

Chicago Style (17th ed.) Citation

Papatsirou, Maria, et al. Exploring the Molecular Biomarker Utility of CircCCT3 in Multiple Myeloma: A Favorable Prognostic Indicator, Particularly for R‐ISS II Patients. Wiley, 2024. https://doi.org/10.1002/hem3.34.

MLA (9th ed.) Citation

Papatsirou, Maria, et al. Exploring the Molecular Biomarker Utility of CircCCT3 in Multiple Myeloma: A Favorable Prognostic Indicator, Particularly for R‐ISS II Patients. Wiley, 2024. https://doi.org/10.1002/hem3.34.